Urinalysis Market Driven by Rising Kidney Diseases and Urinary Tract Infections: Market Size Estimated to Grow by USD 1.04 Billion (2024-2028)

The Urinalysis Market , on a global scale, is set to embark on a substantial growth journey, with a projected Compound Annual Growth Rate (CAGR) of 8.4% estimated between 2023 and 2028. This growth story translates into a significant market size expansion, expected to increase by USD 1.04 Billion. Urinalysis, a pivotal diagnostic tool, plays a crucial role in the detection of conditions such as Urinary Tract Infections (UTIs), renal calculi, proteinuria, glycosuria, ketonuria, and malignancy. Elevated mortality rates linked to Catheter-Associated Urinary Tract Infections (CAUTI), the surging incidence of kidney diseases, and the imperative for early pregnancy detection collectively fuel the demand for urinalysis procedures.

The comprehensive urinalysis process encompasses physical, chemical, and microscopic examinations, making it a time-consuming endeavor. To meet the growing need for effective and efficient clinical diagnostics that offer critical insights in a timely manner, there is a notable surge in Point-of-Care Testing (POCT). Companies are dedicatedly crafting POCT urinalysis products to circumvent infrastructure-related challenges associated with diagnostic instruments. These innovative solutions empower medical practitioners, irrespective of their location, to access advanced diagnostic capabilities. Consequently, these factors will significantly expedite the growth of the global urinalysis market during the forecast period.

For an initial glimpse into market dynamics across diverse regions, we invite you to download our sample report. It offers valuable insights as a preview of the rich information available within the complete report: https://www.technavio.com/urinalysis-market/sample-report

Exploring the Urinalysis Market: Key Drivers, Trends, Challenges, and the Customer Landscape

The growth of the urinalysis market is underpinned by a multitude of factors. Our team of researchers meticulously analyzed data, employing the base year of 2023, in tandem with the critical drivers, trends, and challenges.

Key Urinalysis Market Drivers

The burgeoning prevalence of renal diseases and Urinary Tract Infections (UTIs) stands as a prominent driver of market expansion. The incidence of renal diseases has witnessed a substantial global increase, with the geriatric population being particularly susceptible to developing Chronic Kidney Diseases (CKDs). The prevalence of UTIs has also risen on a global scale, encompassing any segment of the urinary system, ranging from the bladder and urethra to the kidneys. Hospital-acquired Urinary Tract Infections (UTIs), particularly Catheter-Associated UTIs (CAUTIs), constitute one of the most frequently encountered hospital-acquired infections (HAIs). Risk factors for CAUTIs include prolonged catheterization, female gender, older age, and diabetes.

Furthermore, urinary screening serves as a primary approach for diagnosing kidney diseases and UTIs in individuals. Thus, the growing incidence and prevalence of kidney diseases and UTIs foster the growth of the global urinalysis market. In essence, the mounting occurrence of renal diseases and UTIs positions them as catalysts for market expansion during the forecast period.

Significant Urinalysis Market Trends

The burgeoning need for companion diagnostics emerges as a trend of significant consequence, shaping the market's growth. Companion diagnostics, typically in-vitro Point-of-Care (POC) medical devices, deliver essential information that underpins the safe and effective use of corresponding drugs or biological products. Generally, these diagnostics operate based on the analysis provided by the diagnostic device. Companion diagnostics prove crucial for comprehending the unique needs of individual patients and tailoring treatments to suit those needs. This trend has gained prominence in recent times, presenting a promising avenue to introduce POC products to new markets.

Furthermore, the primary advantages of POC urinalysis devices, namely rapid test result turnaround times and heightened mobility, substantially elevate the quality of care and clinical outcomes. This, in turn, leads to enhanced disease management, treatment adherence, and patient satisfaction. Therefore, the growing demand for companion diagnostics is poised to act as a growth catalyst for the global urinalysis market throughout the forecast period.

To gain an in-depth understanding of the Urinalysis Market, encompassing its dynamics, challenges, and prospective growth prospects, we recommend acquiring the complete market report: https://www.technavio.com/urinalysis-market/full-report

Major Urinalysis Market Challenges

The potential for growth in the urinalysis market across emerging economies presents a notable challenge, impeding market expansion. The healthcare sector, encompassing hospitals and clinics, in developing economies is experiencing a rapid growth trajectory. This upswing is attributable to shifting demographics and the simultaneous increase in healthcare expenditure. Emerging economies are witnessing the establishment of both large and mid-sized hospitals, driving demand for advanced screening and diagnostic procedures.

For instance, India, as reported by Institut Montaigne in 2020, boasted a total of 43,486 private and 25,778 public hospitals. Similarly, China, until 2020, had approximately 25,400 hospitals. The burgeoning number of hospitals in developing nations is primarily linked to the population's mounting requirements for the diagnosis and treatment of various medical conditions. This, in turn, is projected to augment demand for diverse medical instruments, including devices and consumables essential for urinalysis. Consequently, these developments are poised to magnify opportunities within the global urinalysis market during the forecast period.